LCM Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Hold |
575
| – | – | 0.16% | 78 |
|
|
2025
Q1 | $365K | Buy |
575
+30
| +6% | +$19K | 0.21% | 64 |
|
|
2024
Q4 | $388K | Buy |
545
+2
| +0.4% | +$1.43K | 0.22% | 64 |
|
|
2024
Q3 | $571K | Buy |
543
+24
| +5% | +$25.2K | 0.33% | 44 |
|
|
2024
Q2 | $545K | Buy |
519
+29
| +6% | +$30.5K | 0.34% | 44 |
|
|
2024
Q1 | $472K | Buy |
490
+4
| +0.8% | +$3.85K | 0.3% | 49 |
|
|
2023
Q4 | $427K | Buy |
486
+12
| +3% | +$10.5K | 0.31% | 48 |
|
|
2023
Q3 | $390K | Buy |
474
+56
| +13% | +$46.1K | 0.32% | 48 |
|
|
2023
Q2 | $300K | Buy |
418
+16
| +4% | +$11.5K | 0.24% | 61 |
|
|
2023
Q1 | $330K | Buy |
402
+53
| +15% | +$43.5K | 0.29% | 55 |
|
|
2022
Q4 | $252K | Buy |
349
+8
| +2% | +$5.77K | 0.25% | 62 |
|
|
2022
Q3 | $235K | Sell |
341
-3
| -0.9% | -$2.07K | 0.25% | 63 |
|
|
2022
Q2 | $203K | Buy |
344
+18
| +6% | +$10.6K | 0.2% | 78 |
|
|
2022
Q1 | $228K | Buy |
+326
| New | +$228K | 0.18% | 82 |
|